Skip to content

3billion vs CENTOGENE

3billion logo

3billion

Your One Answer Genetic testing for rare diseases made more efficient and more accessible

72 employees · est. 2016 · Korea South

VS
CENTOGENE logo

CENTOGENE

Empowering precision medicine through advanced diagnosis 

475 employees · est. 2006 · Rostock, Germany

CENTOGENE is the older company (2016 vs 2006); CENTOGENE is the larger of the two.

Side-by-Side Comparison

3billion CENTOGENE
Founded
2016 2006 older
Headquarters
Korea South Rostock, Germany
Employees
72 475 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care
Funding Stage
IPO IPO
Total Funding
$30.04B $91.80M
Funding Rounds
6 6
Services
Diagnostic Gene Testing, Boosted Exome Analysis, Genome Sequencing, AI Variant Prioritization, Genomic Screenings (3B-NEO), Daily Data Updates, Gene Coverage Browser Whole Genome Sequencing, Multiomic Solutions, Clinical Trial Support, Genetic Testing, Bioinformatics Solutions, Patient Identification, Customized Diagnostics
Target Customers
Patients with Rare Diseases, Healthcare Providers, Medical Geneticists, Diagnostic Laboratories, Pharmaceutical Partners Physicians, Pharmaceutical Companies, Researchers, Medical Institutions, Patients with Rare Diseases
Taxonomy
AI-powered GenomicsRare Disease DiagnosticsGenetic TestingBioinformaticsGenome InterpretationWGS (Whole Genome Sequencing) +6 Genetic DiagnosticsPrecision MedicineRare DiseasesGenetic TestingBiochemical DiagnosticsGenetic Data Interpretation +9
Website
3billion.io centogene.com
3billion logo

About 3billion

3billion, founded in 2016, is revolutionizing the realm of genetic testing for rare diseases by leveraging AI-powered genomics. Headquartered in South Korea, this company is on a mission to make rare disease diagnosis faster, more accurate, and accessible on a global scale. With over 80,000 patient...

CENTOGENE logo

About CENTOGENE

CENTOGENE, headquartered in Germany, is a pioneer in genetic diagnostics and precision medicine. Dedicated to converting clinical, genetic, and biochemical data into actionable medical solutions, the company champions the early diagnosis and treatment of rare diseases. Since its founding in 2006, C...

Also comparing in this category

Comparing more than these two?

Get 3billion, CENTOGENE and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does 3billion compare?

A PDF of 3billion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

3billion was founded in 2016, based in Korea South, with 72 employees. 3billion, founded in 2016, is revolutionizing the realm of genetic testing for rare diseases by leveraging AI-powered genomics. Headquartered in South Korea, this company is on a mission to make rare. CENTOGENE was founded in 2006, based in Rostock, Germany, with 475 employees. CENTOGENE, headquartered in Germany, is a pioneer in genetic diagnostics and precision medicine. Dedicated to converting clinical, genetic, and biochemical data into actionable medical solutions, the.
3billion has raised $30.04B and CENTOGENE $91.80M. Latest stage: 3billion IPO, CENTOGENE IPO.
Both work in Biotechnology and Health Care and list genetic testing among their focus areas.

Compare 3billion with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at 3billion on 15 Jun 2026, and CENTOGENE on 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout